The downstream processing market size is estimated to reach US$ 49.67 billion by the end of 2027, registering a CAGR of 13.65% from 2020 to 2027.
The report provides the overall revenue of the global downstream processing market from 2016 to 2027, considering 2020 as the base year and 2027 as the forecast year.
- Asia Pacific is estimated record firmest growth rate during the prediction period in the downstream processing sector. Nations such as India, China, Japan, and South Korea, are likely to motivate the sale for downstream processing products during years to come
- In 2019, chromatography segment conquered the global downstream processing market revenue with the maximum share of the total market.
- In 2019, North America acquired maximum market share in downstream processing sector and is projected to maintain this strong hold throughout the valuation period
- The antibiotic production segment appeared as most dominating application in 2019
- Growth in of downstream market in evolving countries is powered by substantial funds by vital market performers, cumulative government funding, emergent R&D infrastructure, and mounting proficiency and academic brilliance
We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1072
Escalation in R&D expenditure by biopharmaceutical establishments and uptake in demand for biopharmaceuticals greatly fuels the growth of downstream processing market across the globe. Furthermore, improved demands for novel solutions, cost saving, process optimization, and progress in usage of techniques like centrifuge to distinct biological particles from suspension are some other influences areprompting the growth of downstream processing market. In contrast, requirement for experienced specialists and high price of instruments needed for processing are curtailing the market growth.
A stable upsurge in the recombinant produces and sale for drug quality has compelled the acceptance of downstream processing across the world. The intensification in the perception of large molecules and the biologics is further awaited to motivate the implementation of downstream methodologies.
Report Scope of the Downstream Processing Market
|Market Size||USD 49.67 Billion by 2027|
|Growth Rate||CAGR of 13.65% from 2021 to 2027|
|Fastest Growing Market||Asia Pacific|
|Largest Market||North America|
|Forecast Period||2021 to 2027|
|Segments Covered||Vehicle Class, Architecture, Region|
|Companies Mentioned||General Electric Company, Thermo Fisher Scientific, Inc., Danaher Corporation, Merck & Co Inc., Corning Incorporated, 3M Company, Repligen Corporation, Eppendorf AG, and Lonza Group Ltd|
North America region emerged as leading marketplace for downstream processing and gathered major chunk of the revenue generated by market in 2019. This is attributed to motivating government funding for the preferment of bioprocess technologies, a substantial escalation in medical outlay, and the existence of vigorous healthcare infrastructure. North America has further perceived foremost cooperative activities and the governance of some of the healthcare giants those are expansively making spending in the R&D of vaccines and biopharmaceuticals.
Incessant technical progressions in the biotechnology sector of the U.S. have led to a substantial upsurge in the trade of recombinant products. It is predicted that there would be a 10-fold upsurge in trades during years to come. Hence, constant invention in the bioprocessing and biotechnology area is anticipated to offer growth boulevardsin the U.S. downstream processing marketplace.
Key Players & Strategies
Rapid progresses in escalating upstream procedures for biologics production have left downstream processes as a blockage in the production scheme. Biomanufacturers are chasing unceasing downstream process improvement in order to surge flexibility and competence, diminish cost of goods, and advance product uniformity and superiority.
In line with these efforts, GE declared a Protein A chromatography resin named, MabSelectPrismA, that has augmented alkaline stability and dynamic binding capability. This proposes likelihood to recover the productivity of recent chromatography systems and columns deprived ofpricey capital outlays, constructing more competent practice of the prevailing manufacturing impression. With the help of these supplementary process design choices and tools downstream operations can retain pace with upstream activities and upsurge total productivity in mAb processing.
Corporations that are estimated to endure dynamic in the development of downstream processing marketplace are General Electric Company, Thermo Fisher Scientific, Inc., Danaher Corporation, Merck & Co Inc., Corning Incorporated, 3M Company, Repligen Corporation, Eppendorf AG, and Lonza Group Ltd. These companies are indulging in strategic partnerships, and merger arrangements with other performers to uphold a competitive advantage in the downstream processing marketplace. For example, Sartorius Stedim Biotech partnered with Novasep, in March 2019. They will together improve innovative systems for membrane chromatography and single-use bioprocessing. Such strategic are anticipated to augment the accessibility of cutting-edge products for downstream processing and chromatography, which in turn, is estimated to benefit the progression of downstream processing market.
Segments Covered in the Report
This research study comprises comprehensive assessment of the marketplace revenue with the help of prevalent quantitative and qualitative acumens, and forecasts of the market. This report presents breakdown of market into major and niche segments. Furthermore, this research study gauges market revenue growth and its drift at global, regional, and country from 2016 to 2027. This report includes market division and its revenue assessment by categorizing it depending on product, application, technique and region as follows:
- Chromatography Systems
- Antibodies Production
- Antibiotic Production
- Hormone Production
- Enzyme Production
- Vaccine Production
- Purification by Chromatography
- Solid-liquid Separation
- Cell Disruption
By Regional Outlook
- North America
- Asia Pacific
- South Korea
- Middle East & Africa
- Latin America
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Why Buy this Report?
The purpose of Precedence Research’s downstream processing market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1072
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace &defense, among different ventures present globally.
Call: +1 9197 992 333